DK578887A - Antihypertensiva - Google Patents

Antihypertensiva

Info

Publication number
DK578887A
DK578887A DK578887A DK578887A DK578887A DK 578887 A DK578887 A DK 578887A DK 578887 A DK578887 A DK 578887A DK 578887 A DK578887 A DK 578887A DK 578887 A DK578887 A DK 578887A
Authority
DK
Denmark
Prior art keywords
antihypertensives
certain
relates
enhancement
conjunctive
Prior art date
Application number
DK578887A
Other languages
English (en)
Other versions
DK578887D0 (da
DK167209B1 (da
Inventor
Richard C Dage
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK578887D0 publication Critical patent/DK578887D0/da
Publication of DK578887A publication Critical patent/DK578887A/da
Application granted granted Critical
Publication of DK167209B1 publication Critical patent/DK167209B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK578887A 1986-11-05 1987-11-04 Synergistisk aktivt praeparat til behandling af hypertension DK167209B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92778586A 1986-11-05 1986-11-05
US92778586 1986-11-05

Publications (3)

Publication Number Publication Date
DK578887D0 DK578887D0 (da) 1987-11-04
DK578887A true DK578887A (da) 1988-05-06
DK167209B1 DK167209B1 (da) 1993-09-20

Family

ID=25455252

Family Applications (1)

Application Number Title Priority Date Filing Date
DK578887A DK167209B1 (da) 1986-11-05 1987-11-04 Synergistisk aktivt praeparat til behandling af hypertension

Country Status (11)

Country Link
EP (1) EP0268146B1 (da)
JP (1) JP2612175B2 (da)
KR (1) KR950013758B1 (da)
AT (1) ATE59781T1 (da)
DE (1) DE3767287D1 (da)
DK (1) DK167209B1 (da)
ES (1) ES2036560T3 (da)
GR (1) GR3001375T3 (da)
IE (1) IE59905B1 (da)
PH (1) PH23818A (da)
ZA (1) ZA878182B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU749703B2 (en) * 1997-05-19 2002-07-04 Repros Therapeutics Inc. Combination therapy for modulating the human sexual response
ES2258300T3 (es) * 1997-12-16 2006-08-16 Pfizer Products Inc. Combinacion de antagonistas del receptor alfa-1-adrenergico y un inhibidor gmpc pdev para el tratamiento de la impotencia.
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
EP3167876B1 (en) 2012-03-15 2021-09-08 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
US20130274245A1 (en) * 2012-04-11 2013-10-17 Jan BLUMENSTEIN Composition For Prevention of Vasoactivity in the Treatment of Blood Loss and Anemia
EP3021832B9 (en) 2013-07-19 2023-03-15 Boehringer Ingelheim Vetmedica GmbH Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
CA2930033C (en) 2013-12-04 2022-12-13 Boehringer Ingelheim Vetmedica Gmbh Improved pharmaceutical compositions of pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130647A (en) * 1977-07-08 1978-12-19 Pfizer Inc. Methods for treating congestive heart failure and ischemic heart disease
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation

Also Published As

Publication number Publication date
IE872975L (en) 1988-05-05
PH23818A (en) 1989-11-23
GR3001375T3 (en) 1992-09-11
KR950013758B1 (ko) 1995-11-15
KR880005934A (ko) 1988-07-21
JPS63132837A (ja) 1988-06-04
JP2612175B2 (ja) 1997-05-21
DE3767287D1 (de) 1991-02-14
ES2036560T3 (es) 1993-06-01
ATE59781T1 (de) 1991-01-15
DK578887D0 (da) 1987-11-04
ZA878182B (en) 1988-05-02
EP0268146B1 (en) 1991-01-09
IE59905B1 (en) 1994-04-20
EP0268146A1 (en) 1988-05-25
DK167209B1 (da) 1993-09-20

Similar Documents

Publication Publication Date Title
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
FI864775A7 (fi) Valoa säteilevä kangas lääketieteelliseen hoitoon.
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
ATE16489T1 (de) Aroylimidazolone.
DK578887A (da) Antihypertensiva
ATE39357T1 (de) Derivate von griseolicsaeure und ihre verwendung.
DK462687A (da) Forbindelse til behandling af retrovirusinfektioner.
NO890046D0 (no) Disubstituerte pyridiner.
ES2059457T3 (es) Utilizacion de bezafibrato para el tratamiento de la diabetes.
ES2014438B3 (es) Derivados del acido 2-fosfonobutano-1,2,4tricarboxilico, como agentes emulsivos.
FI864597A0 (fi) Kardiotoniska tiazoloner.
ES2020953B3 (es) Complejos de tetrahidro-3,4-furanodiamina-n-n'platino.
NO871639L (no) Vertikal arkstabler.
DE3686472D1 (de) Cardiotonische phenyloxazolone.
IT8621410A0 (it) Composizione per il miglioramento del candeggio.
ES2024503B3 (es) Mejoras en, o relacionadas con, el reforzamiento del terreno.
NO165917C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt diamino-2,2-difluorhex-5-yn.
SE7909788L (sv) Sett att framstella en antihemofilifaktor
SE7909787L (sv) Sett att framstella en antihemofilifaktor
DE69807200D1 (de) Inklusionskomplexe in waessriger loesung
ATE69609T1 (de) Cardiotonische imidazolylphenylpyrrol-2-one.
DE3776488D1 (da)
ES2003844A4 (es) Medio de tratamiento de cabello con un contenido de acido de almandras d,l
SU1432991A1 (ru) 4-Метил-5-(4-метилфениламино)-1,2,3-триазол, обладающий противовоспалительной активностью

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired